A 58-year-old retired Army officer from Fort Benning sat in the Columbus office last spring and described what I have heard from hundreds of men in his age range: the gym work that built him for thirty years stopped producing results around age 53, his sleep had gone from solid to fragmented, his morning function was nearly absent, and his primary care provider had told him his testosterone was "in the normal range." His total testosterone was 412 ng/dL. His free testosterone — which had not been ordered on the original panel — turned out to be 6.1 pg/mL when we ran it. His SHBG was 58. He was, by any clinically meaningful measure, functionally hypogonadal. The "normal range" reference had hidden it.
I see this every week. The men in their 50s and 60s who come to my office are responding to a real and measurable physiological shift, and most have already been told by the conventional system that nothing is wrong because their total testosterone falls within a reference range built across all adult ages, including 90-year-olds.
What is actually happening physiologically after 50
Testosterone production peaks in a man's early 20s and declines steadily after about age 30 — roughly 1-2% per year on average, though individual trajectories vary considerably. By the time a man hits his 50s, total testosterone has typically dropped 25-40% from its young-adult peak. By the 60s, often more.
But the total testosterone number is only part of the story. Three other things are happening in parallel that matter clinically.
SHBG rises with age. Sex hormone-binding globulin tightly binds testosterone and renders it biologically unavailable. As SHBG increases through the 50s and 60s, the fraction of total testosterone that is actually free and bioavailable drops faster than the total number suggests. A man with a "normal" total testosterone of 450 can be functionally more hypogonadal than a younger man with a total of 350 and healthier SHBG.
Aromatization to estradiol increases. Adipose tissue contains aromatase, the enzyme that converts testosterone to estradiol. As men gain visceral fat through their 50s, aromatase activity rises. More of the testosterone being produced gets shunted to estradiol, which drives further fat gain, sometimes gynecomastia, and worsening sexual function.
LH and FSH dynamics shift. Primary hypogonadism (testicular failure, elevated LH and FSH) and secondary hypogonadism (pituitary or hypothalamic dysfunction, low or inappropriately normal LH and FSH) require different workups. The standard "low T" panel does not distinguish them.
The clinical picture that emerges is what gets called andropause — though I dislike the term because it implies a discrete event when what is actually happening is a slow multi-year decline. Symptoms cluster: fatigue that does not resolve with rest, loss of morning erections, decreased libido, declining muscle despite training, increased central adiposity, mood changes that look like low-grade depression but do not respond well to antidepressants alone, sleep disruption, and cognitive changes.
Why the standard workup misses the diagnosis
I worked 17 years in emergency medicine, cardiac ICU, and the cath lab before transitioning into hormone medicine, and I can tell you with full confidence that the testosterone workup in conventional primary care is, more often than not, inadequate to make the call.
The standard workup is usually a single morning total testosterone. Sometimes a TSH gets added. That panel will catch the most severe primary hypogonadism cases — total testosterone under 200, full clinical picture — and miss almost everyone in the gray zone where 60-70% of mid-life men with symptomatic deficiency actually live.
What is missing from a single total testosterone:
- Free testosterone, the biologically active fraction. SHBG-bound testosterone cannot enter cells. A patient with high SHBG and a "normal" total can have functionally low free testosterone driving every symptom in the book.
- SHBG itself, without which you cannot interpret the total testosterone number meaningfully or calculate the free fraction reliably.
- Estradiol, which tells you whether aromatization is part of the problem and influences treatment strategy significantly.
- LH and FSH, which distinguish primary from secondary hypogonadism.
- A second confirming morning testosterone, because testosterone has diurnal variation and a single measurement can be misleadingly high or low.
- The full thyroid panel, because suboptimal thyroid function mimics and amplifies low testosterone symptoms, and because thyroid status influences SHBG.
- Metabolic markers, because insulin resistance and low testosterone feed each other in a measurable bidirectional way.
When I run the full panel on a man in his 50s who has been told his testosterone is "fine," the finding is functional deficiency more often than reassurance. The lab reference ranges were calculated across populations including men in their 80s — they describe what is statistically common, not what is clinically adequate for a 55-year-old who is symptomatic.
How I evaluate someone for testosterone replacement
The first visit covers history in detail. Symptom inventory using validated tools but also open conversation — many men describe their symptoms differently than the questionnaires capture, and the texture of the description matters. Sleep history, exercise pattern, diet pattern, alcohol intake, current medications and supplements (statins, antidepressants, opioids, certain beta-blockers can all suppress testosterone or contribute to symptom presentation). Personal and family history of prostate disease, cardiovascular disease, blood clots, sleep apnea. Prior testosterone treatment if any, with whatever records you can bring.
The lab panel I order, if you do not already have recent comprehensive results:
- Total and free testosterone (two separate morning draws ideally, between 7 and 10 AM)
- SHBG
- Estradiol (sensitive assay, not the standard female-range assay)
- LH and FSH
- Full thyroid panel: TSH, free T3, free T4, reverse T3, thyroid antibodies
- DHEA-S
- Metabolic panel including fasting insulin, HbA1c, full lipid panel including ApoB
- PSA (baseline and during treatment)
- CBC with hematocrit (testosterone can raise hematocrit; we monitor this)
- hs-CRP, vitamin D, ferritin
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
This is the comprehensive lab work that produces an actual diagnosis rather than a guess. Without this panel, any conversation about whether testosterone replacement is appropriate is informed speculation.
How treatment proceeds
When the lab review confirms functional deficiency and the candidacy criteria are met, men's testosterone replacement is built individually. There is no single protocol that fits every patient.
Delivery method. I have patients on weekly intramuscular or subcutaneous injections (testosterone cypionate, most commonly), patients on daily transdermal preparations, and patients on Biote pellet therapy — pellets implanted under the skin every 4-6 months that release testosterone steadily. The right choice depends on the lab picture, lifestyle, dosing-frequency preference, and prior response. Each has tradeoffs I discuss honestly.
Conservative starting dose. I do not front-load. A patient who feels noticeable improvement at a moderate dose and full optimization at the calibrated dose three months later does substantially better than a patient who was overdosed at the start and now has to manage side effects from a level that was higher than necessary. Conservative titration produces a stable optimal level rather than oscillation.
Adjunctive therapy where indicated. For patients whose estradiol rises into a problematic range, low-dose anastrozole is sometimes added — but sparingly, and only when the lab data supports it. Crashing estradiol in a man causes its own set of problems. For patients preserving fertility, hCG or enclomiphene may be appropriate.
Monitoring schedule. Labs at 6-8 weeks after initiation, again at 3 months for dose refinement, then every 6-12 months. PSA and hematocrit tracked at every recheck.
What I look for in good candidates and what disqualifies someone
Good candidates: a clinical picture consistent with functional testosterone deficiency, lab confirmation that aligns with the symptoms, willingness to do follow-up labs and engage with the protocol over time, and absence of contraindications. Realistic expectations matter — testosterone replacement is not a fountain of youth and it is not a substitute for sleep, training, and nutrition. It restores a physiological signal that has weakened. The downstream benefits depend partly on what you do with the restored signal.
Less-good candidates or active contraindications: untreated or active prostate cancer, breast cancer, severe untreated sleep apnea (testosterone can worsen it; we treat the apnea first), elevated baseline hematocrit above 54%, recent cardiovascular event without cardiology clearance, planned fertility in the near term without an adjunctive protocol, and patients whose symptoms are better explained by another untreated condition.
I send a meaningful percentage of men to other specialists at the workup stage rather than starting them on testosterone — sleep apnea workups, cardiology referrals, mental health support when mood symptoms predate any hormone change. Treating an undiagnosed adjacent problem with testosterone is not in anyone's interest.
The realistic timeline
What to expect over the first year:
- Weeks 2-4: sleep often improves first. Energy follows. Morning function may start to return. Mood lifts in some patients this early; for others it takes longer.
- Weeks 6-8: mood and cognitive symptoms more consistently improved. Libido response is variable in timing — some men notice it in the first month, others not until month three.
- Month 3: first full lab reassessment. Dose typically refined. PSA and hematocrit checked. By this point most men have a clear sense of whether the protocol is working.
- Months 3-6: body composition starts shifting. Lean mass increases with continued resistance training. Visceral fat decreases. The training that stopped producing results in your early 50s starts producing results again.
- Months 6-12: sustained optimization. Stable lab values, stable symptom response, stable protocol. Annual reassessment cadence established.
Patients in my practice who understand this timeline and engage with the framework — show up for the labs, do the protein and training work, treat the adjacent factors — get the outcomes the literature predicts. Patients who expect transformation in week two and quit before the calibrated dose is reached do not.
A concrete next step
If you recognize yourself in this article — symptoms that match, prior workups that came back "normal" without including free testosterone, SHBG, or the full thyroid panel — the highest-yield next step is the comprehensive lab panel I described above, drawn between 7 and 10 AM, with both total and free testosterone, SHBG, estradiol (sensitive assay), LH, FSH, and the full thyroid and metabolic markers.
Bring whatever prior lab work you have, even if it was incomplete. Bring a list of current medications and supplements. Bring whatever history you have on prostate health and cardiovascular history. The first visit covers history and orders the labs if needed. The second visit is the lab review and the actual treatment-plan conversation.
You can book a consultation at either the Columbus or Warner Robins office. The patients in middle Georgia I have worked with — Fort Benning retirees, Warner Robins industry workers, Columbus professionals — have one thing in common when they do well: they took the workup seriously, stayed engaged with the follow-up, and were honest about what they were experiencing along the way. That is what produces the result that lasts.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.